← Back to Search

Immunotherapy

Arm 1 for Food Allergy

Phase 1 & 2
Waitlist Available
Research Sponsored by Alladapt Immunotherapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Study Summary

This trial will test if ADP101 is an effective and safe treatment for food allergies in children and adults.

Eligible Conditions
  • Food Allergy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Food Allergy Desensitization
Secondary outcome measures
Incidence of adverse events, including serious adverse events during the study period (Safety and Tolerability)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2Experimental Treatment1 Intervention
Group II: Arm 1Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ADP101 vs Placebo Dose Regimen A
2021
Completed Phase 2
~80
ADP101 vs Placebo Dose Regimen B
2021
Completed Phase 2
~80

Find a Location

Who is running the clinical trial?

Alladapt Immunotherapeutics, Inc.Lead Sponsor
1 Previous Clinical Trials
45 Total Patients Enrolled
1 Trials studying Food Allergy
45 Patients Enrolled for Food Allergy
Mei-Lun Wang, MDStudy DirectorVP of Clinical Development, Alladapt Immunotherapeutics, Inc.
1 Previous Clinical Trials
45 Total Patients Enrolled
1 Trials studying Food Allergy
45 Patients Enrolled for Food Allergy

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults
2021. "ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04856865.
~18 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top